Tag Archives: insys

December, 2018

August, 2018

December, 2017

July, 2016

  • 5 July

    FDA Approves Insys’ Cannabis-Based Drug for Cancer, AIDS-Related Weight Loss

    PHOENIX, July 05, 2016 (GLOBE NEWSWIRE) — Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today announced that the U.S. Food and Drug Administration (FDA) has approved Insys’ dronabinol oral solution, SyndrosTM, an orally administered liquid formulation of the pharmaceutical cannabinoid dronabinol, a pharmaceutical version of tetrahydrocannabinol (“THC”).  Syndros is …

January, 2015